M2 EQUITYBITES-March 20, 2015-Canadian Unit of China's Phagelux to Acquire
Biophage Pharma
This transaction remains subject to approval by
Biophage shareholders and the AutoritA(c) des marchA(c)s financiers, as well as NEX.
The developed technology will be patented by the research teams involved and will be validated at a Canadian industrial facility, '
BioPhage Pharma', which will also commercialise it.
Biophage Pharma is a Canadian biotechnology company focused on the development of innovative phage-based products and technologies for the detection, prevention, and control of bacterial infections.